OPKO Health, Inc. Increase (Decrease) in Accounts Payable
OPKO Health, Inc. (OPK) reported Increase (Decrease) in Accounts Payable of $8.87 million for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-28
- OPKO Health, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $5.37M.
- OPKO Health, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $3.50M, a 69.53% decline year-over-year.
- OPKO Health, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$17.06M.
- OPKO Health, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$5.24M.
- OPKO Health, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$14.22M.
- OPKO Health, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$20.66M, a 830.62% decline from fiscal 2023.
- OPKO Health, Inc. increase (decrease) in accounts payable for fiscal 2023 was $2.83M.
- OPKO Health, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$9.39M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $5.37M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $8.87M 10-Q/A · filed 2026-08-28 | -$8.20M derived: sum of 3 quarters · filed 2026-08-28 | -$13.44M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2026-03-31 | $3.50M 10-Q/A · filed 2026-08-28 | -$13.56M derived: sum of 2 quarters · filed 2026-08-28 | -$18.81M derived: sum of 3 quarters · filed 2026-08-28 | -$22.20M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-12-31 | -$17.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$22.30M derived: sum of 2 quarters · filed 2026-02-26 | -$25.69M derived: sum of 3 quarters · filed 2026-08-28 | -$14.22M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$5.24M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | -$8.63M derived: sum of 2 quarters · filed 2026-08-28 | $2.84M 10-Q · filed 2025-10-29 | -$11.29M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-06-30 | -$3.39M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $8.09M 10-Q/A · filed 2026-08-28 | -$6.05M derived: sum of 3 quarters · filed 2026-08-28 | -$26.26M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2025-03-31 | $11.47M 10-Q/A · filed 2026-08-28 | -$2.66M derived: sum of 2 quarters · filed 2026-08-28 | -$22.88M derived: sum of 3 quarters · filed 2026-08-28 | -$11.98M derived: sum of 4 quarters · filed 2026-08-28 | |
| 2024-12-31 | -$14.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$34.35M derived: sum of 2 quarters · filed 2026-02-26 | -$23.45M derived: sum of 3 quarters · filed 2026-02-26 | -$20.66M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$20.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$9.32M derived: sum of 2 quarters · filed 2025-10-29 | -$6.53M 10-Q · filed 2025-10-29 | -$3.89M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $10.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $13.69M 10-Q · filed 2025-07-31 | $16.32M derived: sum of 3 quarters · filed 2026-02-26 | -$3.69M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $2.79M 10-Q · filed 2025-05-01 | $5.43M derived: sum of 2 quarters · filed 2026-02-26 | -$14.59M derived: sum of 3 quarters · filed 2026-02-26 | -$7.14M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$17.38M derived: sum of 2 quarters · filed 2026-02-26 | -$9.93M derived: sum of 3 quarters · filed 2026-02-26 | $2.83M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$20.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$12.57M derived: sum of 2 quarters · filed 2024-11-07 | $191.00K 10-Q · filed 2024-11-07 | $15.80M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $7.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $20.21M 10-Q · filed 2024-08-07 | $35.82M derived: sum of 3 quarters · filed 2025-03-03 | $30.33M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $12.76M 10-Q · filed 2024-05-07 | $28.37M derived: sum of 2 quarters · filed 2025-03-03 | $22.88M derived: sum of 3 quarters · filed 2025-03-03 | -$12.77M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $15.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $10.12M derived: sum of 2 quarters · filed 2025-03-03 | -$25.53M derived: sum of 3 quarters · filed 2025-03-03 | -$9.39M 10-K · filed 2025-03-03 | |
| 2022-09-30 | -$5.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$41.14M derived: sum of 2 quarters · filed 2023-11-06 | -$25.00M 10-Q · filed 2023-11-06 | -$31.10M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-06-30 | -$35.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$19.51M 10-Q · filed 2023-08-03 | -$25.61M derived: sum of 3 quarters · filed 2024-03-01 | -$18.70M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2022-03-31 | $16.14M 10-Q · filed 2023-05-03 | $10.04M derived: sum of 2 quarters · filed 2024-03-01 | $16.95M derived: sum of 3 quarters · filed 2024-03-01 | -$56.94M derived: sum of 4 quarters · filed 2024-03-01 | |
| 2021-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $804.00K derived: sum of 2 quarters · filed 2024-03-01 | -$73.08M derived: sum of 3 quarters · filed 2024-03-01 | -$10.85M 10-K · filed 2024-03-01 | |
| 2021-09-30 | $6.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$66.98M derived: sum of 2 quarters · filed 2022-11-08 | -$4.75M 10-Q · filed 2022-11-08 | $29.15M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | -$73.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$11.65M 10-Q · filed 2022-08-04 | $22.25M derived: sum of 3 quarters · filed 2023-02-27 | $42.26M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $62.23M 10-Q · filed 2022-05-09 | $96.13M derived: sum of 2 quarters · filed 2023-02-27 | $116.14M derived: sum of 3 quarters · filed 2023-02-27 | $104.25M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $33.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $53.91M derived: sum of 2 quarters · filed 2023-02-27 | $42.02M derived: sum of 3 quarters · filed 2023-02-27 | $37.16M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $20.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $8.13M derived: sum of 2 quarters · filed 2021-10-28 | $3.26M 10-Q · filed 2021-10-28 | -$11.70M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | -$11.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$16.75M 10-Q · filed 2021-07-29 | -$31.71M derived: sum of 3 quarters · filed 2022-03-01 | -$14.00M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$4.87M 10-Q · filed 2021-04-28 | -$19.83M derived: sum of 2 quarters · filed 2022-03-01 | -$2.12M derived: sum of 3 quarters · filed 2022-03-01 | $7.06M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$14.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.75M derived: sum of 2 quarters · filed 2022-03-01 | $11.92M derived: sum of 3 quarters · filed 2022-03-01 | $15.64M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $17.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $26.88M derived: sum of 2 quarters · filed 2020-10-29 | $30.60M 10-Q · filed 2020-10-29 | $13.84M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-06-30 | $9.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $12.89M 10-Q · filed 2020-07-31 | -$3.87M derived: sum of 3 quarters · filed 2021-02-18 | -$5.10M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2019-03-31 | $3.71M 10-Q · filed 2020-05-06 | -$13.04M derived: sum of 2 quarters · filed 2021-02-18 | -$14.28M derived: sum of 3 quarters · filed 2021-02-18 | -$12.16M derived: sum of 4 quarters · filed 2021-02-18 | |
| 2018-12-31 | -$16.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$17.99M derived: sum of 2 quarters · filed 2021-02-18 | -$15.88M derived: sum of 3 quarters · filed 2021-02-18 | -$26.08M 10-K · filed 2021-02-18 | |
| 2018-09-30 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $877.00K derived: sum of 2 quarters · filed 2019-11-05 | -$9.33M 10-Q · filed 2019-11-05 | -$1.17M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$8.09M 10-Q · filed 2019-08-07 | $66.00K derived: sum of 3 quarters · filed 2020-03-02 | $2.64M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$10.21M 10-Q · filed 2019-05-08 | -$2.05M derived: sum of 2 quarters · filed 2020-03-02 | $526.00K derived: sum of 3 quarters · filed 2020-03-02 | -$9.57M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $8.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $10.73M derived: sum of 2 quarters · filed 2020-03-02 | $632.00K derived: sum of 3 quarters · filed 2020-03-02 | $20.17M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$7.53M derived: sum of 2 quarters · filed 2018-11-09 | $12.01M 10-Q · filed 2018-11-09 | $8.34M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$10.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $9.44M 10-Q · filed 2018-08-07 | $5.76M derived: sum of 3 quarters · filed 2019-03-01 | $2.83M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $19.54M 10-Q · filed 2018-05-08 | $15.86M derived: sum of 2 quarters · filed 2019-03-01 | $12.93M derived: sum of 3 quarters · filed 2019-03-01 | $69.00K derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$6.61M derived: sum of 2 quarters · filed 2019-03-01 | -$19.47M derived: sum of 3 quarters · filed 2019-03-01 | -$19.82M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$15.79M derived: sum of 2 quarters · filed 2017-11-08 | -$16.14M 10-Q · filed 2017-11-08 | $1.24M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2016-06-30 | -$12.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$13.21M 10-Q · filed 2017-08-08 | $4.18M derived: sum of 3 quarters · filed 2019-01-29 | -$38.43M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2016-03-31 | -$349.00K 10-Q · filed 2017-05-10 | $17.03M derived: sum of 2 quarters · filed 2019-01-29 | -$25.57M derived: sum of 3 quarters · filed 2019-01-29 | -$20.58M derived: sum of 4 quarters · filed 2019-01-29 | |
| 2015-12-31 | $17.38M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | -$25.22M derived: sum of 2 quarters · filed 2019-01-29 | -$20.23M derived: sum of 3 quarters · filed 2019-01-29 | -$18.12M 8-K · filed 2019-01-29 | |
| 2015-09-30 | -$42.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$37.61M derived: sum of 2 quarters · filed 2016-11-07 | -$35.50M 10-Q · filed 2016-11-07 | -$35.51M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $7.10M 10-Q · filed 2016-08-08 | $7.10M derived: sum of 3 quarters · filed 2017-03-01 | $6.56M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | $2.11M 10-Q · filed 2016-05-09 | $2.10M derived: sum of 2 quarters · filed 2017-03-01 | $1.56M derived: sum of 3 quarters · filed 2017-03-01 | -$3.22M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$544.00K derived: sum of 2 quarters · filed 2017-03-01 | -$5.33M derived: sum of 3 quarters · filed 2017-03-01 | -$3.85M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$5.33M derived: sum of 2 quarters · filed 2015-11-09 | -$3.85M 10-Q · filed 2015-11-09 | -$4.32M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$4.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$3.31M 10-Q · filed 2015-08-05 | -$3.78M derived: sum of 3 quarters · filed 2016-02-29 | -$1.81M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $1.48M 10-Q · filed 2015-05-11 | $1.00M derived: sum of 2 quarters · filed 2016-02-29 | $2.98M derived: sum of 3 quarters · filed 2016-02-29 | $3.41M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | -$474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.50M derived: sum of 2 quarters · filed 2016-02-29 | $1.93M derived: sum of 3 quarters · filed 2016-02-29 | $1.83M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $2.41M derived: sum of 2 quarters · filed 2014-11-07 | $2.30M 10-Q · filed 2014-11-07 | $3.88M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-06-30 | $436.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $333.00K 10-Q · filed 2014-08-11 | $1.91M derived: sum of 3 quarters · filed 2015-02-27 | $2.38M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2013-03-31 | -$103.00K 10-Q · filed 2014-05-09 | $1.48M derived: sum of 2 quarters · filed 2015-02-27 | $1.94M derived: sum of 3 quarters · filed 2015-02-27 | $1.42M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $2.04M derived: sum of 2 quarters · filed 2015-02-27 | $1.52M derived: sum of 3 quarters · filed 2015-02-27 | $1.25M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $465.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$60.00K derived: sum of 2 quarters · filed 2013-11-12 | -$331.00K 10-Q · filed 2013-11-12 | $1.54M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-06-30 | -$525.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$796.00K 10-Q · filed 2013-08-09 | $1.07M derived: sum of 3 quarters · filed 2014-03-03 | $1.13M derived: sum of 4 quarters · filed 2014-03-03 | |
| 2012-03-31 | -$271.00K 10-Q · filed 2013-05-10 | $1.60M derived: sum of 2 quarters · filed 2014-03-03 | $1.66M derived: sum of 3 quarters · filed 2014-03-03 | $94.00K derived: sum of 4 quarters · filed 2014-03-03 | |
| 2011-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $1.93M derived: sum of 2 quarters · filed 2014-03-03 | $365.00K derived: sum of 3 quarters · filed 2014-03-03 | -$1.78M 10-K · filed 2014-03-03 | |
| 2011-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.50M derived: sum of 2 quarters · filed 2012-11-09 | -$3.65M 10-Q · filed 2012-11-09 | -$3.53M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$3.71M 10-Q · filed 2012-08-09 | -$4.25M 10-Q · filed 2011-08-08 | -$3.59M derived: sum of 3 quarters · filed 2013-03-18 | -$3.54M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | -$2.15M 10-Q · filed 2012-05-10 | -$2.02M derived: sum of 2 quarters · filed 2013-03-18 | -$1.98M derived: sum of 3 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $167.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.50M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $1.37M 10-Q · filed 2011-11-09 | |||
| 2010-06-30 | $1.33M 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | -$547.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |